CHARACTERISATION OF FLAVONOID GLYCOSIDES IN PHARMACOPOEIAL PREPARATION OF CISSUS VERTICILLATA (L) NICOLSON & C. E. JARVIS) USING HPLC-DAD AND HPLC-MS
HTML Full TextCHARACTERISATION OF FLAVONOID GLYCOSIDES IN PHARMACOPOEIAL PREPARATION OF CISSUS VERTICILLATA (L) NICOLSON & C. E. JARVIS) USING HPLC-DAD AND HPLC-MS
W. L. R. Barbosa*1, F. F. Vincieri 2, S. Gallori2, L. N. Pinto 1, A. S. B. Silva 1 and J. N. Anunciacao 1
Laboratory of Chromatography and Mass Spectrometry, Faculty of Pharmacy, Institute of Health Sciences, Federal University of Pará 1, Rua Augusto Corrêa, nº 01, CEP 66075-110, Guamá, Belém, Pará, Brazil
Department of Pharmaceutical Sciences, University of Florence 2, Florence, Italy
ABSTRACT: According to Brazilian regulation, the registration of phytomedicines must inform the characterisation of, at least, one of their constituent. In order to contribute to this goal, a tincture of Cissus verticillata (L.) Nicolson & C.E. Jarvis prepared with ethanol 96oGL was investigated. This plant species is widely used due its hypoglycaemic properties, to control diabetes, and empirically to treat the consequence of cerebral vascular accident. Thus, this work reports the evaluation of the flavonoid content in the tincture and the characterisation of flavonoid glycosides, because flavonoids can be part of the active constituents of this herbal drug, and also because these substances can be used as markers. This article both confirms the presence of several flavonoids previously detected in this herbal drug and reports the presence of others not previously described and are characterised in this species for the first time. The flavonoid content in the tincture, determined as Rutin using UV spectroscopy, is 3.6g% of tincture. A method based on reversed phase (RP) HPLC analysis was developed and allowed good separation of the flavonoids found in C. verticillata. Aglycones and both O- and C-derivatives of the flavonoids are easily and also adequately separated.
Keywords: |
Vitexin, Isovitexin, Homoorientin, Schaftoside, Isoschaftoside, Medicinal Plants, Phytotherapy
INTRODUCTION:Medicinal plants, according to the Brazilian regulation, must be standardized in order to be introduced in the basic health system or used in the development of a phytomedicine 1. Tinctures, used in the pharmaceutical praxis as component of phytomedicines, are very useful pharmacopeic derivatives of plant material; they can be manipulated as ingredients in many liquid formulations, and can also be used after evaporation to dryness in solid and semi-solid formulations.
The Brazilian Pharmacopoeia contains a general monograph about tinctures in which the mode of preparation and the proportion of the herbal drugs in the extract are specified 2. Many tinctures marketed in Brazil are prepared with ethanol 70ºGL or absolute ethanol, depending on the metabolic class to be extracted.
The leaves of Cissus verticillata has alleged popular use as hypoglycemic remedy in Northern (Amazonia) 3, in Northeastern 4 and Southern Brazil 5. The detection of phenolic compound in the secretion of idioblasts as well the occurrence of flavonoids glycosides in this plants species corroborate the objective of this work since flavonoids are already detected in Cissus and show hypoglycemic activity 6.
Our group investigated the aqueous extract and the tincture prepared from Cissus verticillata. The hypoglycaemic property of this herbal drug was determined in rats treated with aqueous extract in which the presence of flavonoids glycosides could be observed 7, the same results were observed for Cissus quandrangularis rhizome extract 8. Likewise, the acute exposition of humans to a decoction of dried leaves of the plant produces hypoglycaemic effect at 120 minutes 9.
A methanol fraction containing Tyramine obtained from a lyophilised aqueous extract of C. verticillata shows antioxidant activity on Alloxan-induced diabetic rats as reported by Viana et al 10.
Our group works investigating substances present in pharmacopeic preparations obtained from medicinal plants, which can be used to standardise the plant species, its derivatives and products. Here, we report the flavonoid content of the tincture prepared from leaves of C. verticillata. The chromatographic profile of flavonoids from C. verticillata shows peaks with retention times and spectra very similar to those obtained from Passiflora incarnata L. (Passionflower).
MATERIALS AND METHODS:
Solvents: The water used as eluent was purified by a Milli-Qplus® system from Millipore (Milford, MA, USA) and acidified to pH = 3.2 by addition of 85% formic acid obtained from Carlo Erba (Milan, Italy); HPLC-grade Acetonitrile and Methanol were from Merck (Darmstadt, Germany).
Standards and Materials: Genuine samples of Vitexin, Isovitexin and Homoorientin were purchased from Extrasynthese S.A. (Lyon, Nord Genay, France). PTFE membrane filters 0.2 µm from Waters Co. (Milford, MA).
Sample Preparation: The tincture was obtained according to methods described in Brazilian Pharmacopoeia 1, from 200g of dried und grinded leaves of Cissus verticillata (L) Nicolson & C. E. Jarvis) by maceration with 1 L ethanol 96oGL.
Determination of the Total Flavonoids content: The total flavonoid content was determined using a procedure based on the method developed and validated by Silva 12 where 500 mg of extract were treated with methanol, under reflux. The methanolic solution is taken to 50 mL, from which 10 mL are partitioned between water and chloroform. The hydromethanolic phase added of glacial acetic acid, pyridine and methanolic solution of aluminium chloride is analysed under UV light at 420 nm. The total content in flavonoids is expressed in grams of Rutin per 100g of tincture.
Instrumentation for HPLC-DAD Analysis: The analysis was conducted using an 1100 liquid chromatograph equipped with DAD detector from Agilent Technologies (Palo Alto, CA, USA). Compounds were separated on a 250mm x 4.6mm i.d., 5µm particle, LiChroCART PuroSphere® STAR RP-18 (4µ) equipped with a 4 x 3.0 mm pre-column of the same phase operating at 26°C. The mobile phase was prepared with water containing formic acid (pH 3.2) (A), acetonitrile (B) and methanol (C) in a five-step linear gradient: t=0 min A 100%; at t=5 min A 85% and B 15%; at t=25min A 75% and B 25% and so until t=40min, from this time on, 100% C were used during more 5min.
The flow rate was 0.8 mL min-1. Before analysis tincture of C. verticillata was filtered through PTFE membrane filters 0.2 µm. The volume of sample solution injected was 10 µL. UV-Vis spectra were recorded in the range 190-450nm, and chromatograms were acquired at 230, 254, 280, 330 and 350 nm. Typical chromatograms at 280 nm and at 350 nm of Cissus (CIS9POS) and comparison with Passionflower (PASSIEU) samples are depicted in figure 1 and 2, respectively.
Instrumentation for HPLC-MS Analysis: The analysis was conducted using 1100 MS detector interfaced to the above-described HPLC system by an 1100 MSD API-electrospray (ESI), instruments from Agilent Technologies (Palo Alto, CA, USA). The interface geometry, orthogonal positioning of the nebulizer relative to the capillary inlet, enabled the use of analytical conditions similar to those used for HPLC-DAD analysis.
The conditions used for mass spectrometry (gas temperature 350oC at a flow rate of 10L.min-1, nebulizer pressure 30psi, quadrupole temperature 30oC and capillary voltage 3500 V) were optimized to achieve the maximum sensitivity of ESI values.
The column, time and flow rate used were the same as those described above, without appreciable variation of the chromatographic profile. Full scan spectra from 100 m/z to 800 m/z were obtained in positive-ion mode; the scan time was 1 s. The volume of sample solution injected was 10µL.
Identification of Constituents: The structural identification of each compound was carried out mainly based on its UV spectrum, retention time on reverse phase, and MS spectra obtained by applying different fragmentation energies with the API/ESI technique.
Moreover, the use of standard reference compounds and/or laboratory extracts helped to complete the identification.
RESULTS AND DISCUSSION: The table 1 shows the comparison of HPLC-MS data obtained from a tincture of C. verticillata to those of Passiflora incarnata which allows characterising the compounds listed therein 8, 13. All peaks show very similar retention time in both chromatograms (Figure 1 and 2).
TABLE 1: DATA OF C. VERTICILLATA COMPARED TO LC-MS AND UV DATA OF P. INCARNATA 7
Cissus verticillata | Passiflora incarnata | UV | |||||
Peaks | [M+H]+ | Rt | Substance | Peaks | Rt | Substance | |
A | 595 | 15.11 | Vicenin-2 (apigenin-6,8-di-C-glucoside) | Abis | 15.06 | Vicenin-2 | 274, 334 |
B | 565 | 16.94 | Isoshaftoside
(apigenin-6-C-arabino-8-C-glucoside) |
Bbis | 16.87 | Isoshaftoside | 274, 334 |
C | 565 | 17.79 | Shaftoside
(apigenin-6-C-glucosyl-8-C-arabinoside) |
Cbis | 17.69 | Shaftoside | 274, 334 |
D | - | 18.65 | Homoorientin (luteolin-8-C-glucoside) | Dbis | 18.64 | Homoorientin | 255, 267, 293(sh), 346 |
E | 565 | 18.96 | structural isomer of isoshaftoside | Ebis | 18.97 | not reported | 274, 334 (observed) |
F | 565 | 19.32 | structural isomer of shaftoside | Fbis | 19.30 | not reported | 274, 334 (observed) |
G | 433 | 22.80 | Vitexin (apigenin-8-C-glucoside) | Gbis | 22.72 | Vitexin | 270, 303(sh), 335 |
H | 433 | 23.06 | isovitexin (apigenin-6-C-glucoside) | Hbis | 23.02 | Isovitexin | 271, 334 |
[M+H]+ data in m/z and UV in nm
A
B
FIGURE 1: CHROMATOGRAPHIC PROFILE AT 280nm (a) AND 350nm (b) OF CISSUS VERTICILLATA
FIGURE 2: CHROMATOGRAMS AT 350 nm OF CISSUS VERTICILLATA (c) AND PASSION FLOWER (d)
Comparing retention times, UV-Vis and mass spectra of these substances to those obtained from Passiflora incarnata and using the information available in the literature 14 the flavonosides of C. verticillata could be characterised. The peaks A and Abis present analogous mass spectra in positive mode exhibiting [M+H]+ and [M+Na]+ ions at m/z 595 and 617.
The structure of peak A, the most polar glycoside in the sample, was mainly determined by the fragmentation pattern of its MS spectrum in negative ion mode in agreement with a previous report 15 and due the UV-Spectrum showed in Figure 3. These data suggest the presence of an apigenin nucleus bounded to two glucose moieties, and thus it could be characterised as vicenin-2 or apigenin-6, 8-di-C-glucoside 16.
FIGURE 3: UV SPECTRUM CORRESPONDING TO PEAK A, VICENIN-2
Peaks B/Bbis and C/Cbis exhibited [M+H]+ and [M+Na]+ ions at m/z 565 and 587. These data suggested the presence of an apigenin nucleus plus a pentose and glucose. However, the absence, in both spectra, of peaks generated by the fragment ions [M+H-162]+, [M+H-132]+ or [M+H-(162+132)]+ at m/z 403, 433 and 271 (corresponding to the aglycone apigenin) suggested that peaks B, Bbis, C and Cbis were 6,8-C-glycosides of apigenin. These suggestions were confirmed by the typical fragment ions [M+ H-H2O]+ and [M+H-2H2O]+ that were evidenced at m/z 547 and 529. Other characteristic fragment ions [M+H- 2H2O-CH2O]+, [M+H-5H2O-CH2O]+ and [M+H- 6H2O-CH2O]+ were also evidenced at m/z 499, 445 and 427. From these data, peak B and C were putatively assigned to 6-C-arabinosyl-8-C-glucosylapigenin (isoshaftoside) and 6-C-glucosyl-8-C-arabinosylapigenin (shaft-oside) respectively. Figure 4 and 5 show the UV spectra corresponding to peak B and C.
FIGURE 4: UV SPECTRUM CORRESPONDING TO PEAK B (ISOSCHAFTOSIDE)
FIGURE 5: UV SPECTRUM CORRESPONDING TO PEAK C (SCHAFTOSIDE)
Peak D (minor constituent) was identified as homoorientin, by comparison of chromatographic and spectroscopic data with authentic samples.
Peaks E (minor constituent) and F (minor constituent) exhibited [M+H]+ and [M+Na]+ ions at m/z 565 and 587. These data suggested the presence of an apigenin nucleus plus a pentose and glucose. Also here the absence, in both spectra, of peaks generated by the fragment ions [M+H-162]+, [M+H-132]+ or [M+H-(162+132)]+ at m/z 403, 433 and 271 (corresponding to the aglycone apigenin) suggested that peaks E and Ebis were 6,8-C-glycosides of apigenin.
These suggestions were confirmed by the typical fragment ions [M+ H-H2O]+ and [M+H-2H2O]+ that were evidenced at m/z 547 and 529. Other characteristic fragment ions [M+H- 2H2O-CH2O]+ and [M+H-5H2O-CH2O]+ were also evidenced at m/z 499 and 445. No differentiation was found between mass spectra of peak B putatively assigned to isoshaftoside and compound E and between mass spectra of peak C putatively assigned to shaftoside and compound F.
From these data, the minor constituents, peaks E and F, were identified as structural isomers of apigenin-6, 8-di-C-glycoside 16, as demonstrates Figure 6 which shows similar spectra for both substances.
FIGURE 6: UV SPECTRA CORRESPONDING TO THE PEAKS E AND F
The peaks G and H at 22.80 min and 23.06 min respectively in the HPLC-DAD chromatograms of Cissus were identified as Vitexin and isovitexin respectively by comparison their chromatographic and spectroscopic data with authentic samples. These results allow to conclude that the tincture of Cissus verticillata at 96oGL contain at least eight flavonoid glycosides which can be used as quality markers of plant material, its derivatives and products. The detection and characterisation of these substances in pharmacopeic preparations, using LC-DAD and LC-MS, can be very useful in developing phytomedicines, once the isolation and characterisation of these substances by chromatographic and spectrometric usual methods demands more plant material, chemicals and time.
ACKNOWLEDGMENT: The authors are grateful to the National Council for Scientific and Technologic Development – CNPq, Coordination for the Improvement of Higher Education Personnel – CAPES, Foundation Pará Amazonia - FAPESPA and the Federal University of Pará – UFPA for material support.
REFERENCE:
- Barbosa WLR, Nascimento MS, Pinto LN, Maia FLC, Sousa AJA, Silva Júnior JOC, Monteiro MM, Oliveira DR. Selecting Medicinal Plants for Development of Phytomedicine and Use in Primary Health Care, Bioactive Compounds in Phytomedicine, Iraj Rasooli (Ed.), 2012, ISBN: 978-953-307-805-2, InTech, DOI: 10.5772/26078. Available from: http://www.intechopen. com/books/bioactive-compounds-in-phytomedicine/selecting-medicinal-plants-for-development-of-phytomedicine-and-use-in-primary-health-care
- Brasil. Farmacopeia Brasileira, 5th Edition, Agência Nacional de Vigilância Sanitária. Brasília: ANVISA, 2010.
- Pinto LN, Barbosa WLR. Plantas medicinais utilizadas por comunidades do município de Igarapé-Miri, Pará: Etnofarmácia do município de Igarapé Miri – PA, Etnofarmácia: Fitoterapia Popular e Ciência Farmacêutica Wagner LR Barbosa (Org.). 2010, ISBN: 978-85-8042-215-3. Editora CRV. Available from: http://www.editoracrv.com.br/
- Mota RS, Dias HM. Quilombolas group and medicinal forest resources in southern Bahia, Brazil. INTERAÇÕES, 2012, 13(2): 151-159.
- Trojan-Rodrigues M, Alves TLS, Soares GLG, Rittera MR: Plants used as antidiabetics in popular medicine in Rio Grande do Sul, southern Brazil. J. of Ethnopharmacol., 2012; 139(1): 155–163.
- Oliveira AB, Mendonça MS, Azevedo AA, Meira RMSA. Anatomy and histochemistry of the vegetative organs of Cissus verticillata - a native medicinal plant of the Brazilian Amazon. Rev. Bras. Farmacogn., 2012 22(6): 1201-1211.
- Barbosa WLR, dos Santos WRA, Pinto LN, Tavares ICC: Flavonoides de Cissus verticillata e a atividade hipoglicemiante do chá de suas folhas. Rev. Bras. Farmacogn. 2002, 12 (suppl), 13-15.
- Vijayakumari P, Shanthi K, Bharathi K, Kayalvizhi J, Muruganantham G, Sethuraman M, Thirumurugan V: Studies on the Physico-Phytochemical and Anti-diabetic Properties of Cissus quadrangularis L. and Solanum torvum Swartz. Int J of Drug Discovery and Herbal Research. 2012; 2(1): 323-328
- Santos HB, Modesto-Filho J, Diniz MFFM, de Vasconcelos THC, Pereira FSB, Ramalho JA, Dantas JG, Santos EB: Avaliação do efeito hipoglicemiante de Cissus sicyoides em estudos clínicos fase II. Rev. Bras. Farmacogn. 2008; 18(1): 70-76.
- Lino CS, Sales TP, Alexandre FSO, Ferreira JM, Sousa DF, Gomes PB, do Amaral JF, Maia FD, Silveira ER, de Queiroz MGR, de Sousa FCF, Viana GSB: Antioxidant activity of a Cissus verticillata fraction and tyramine, its bioactive constituent, on alloxan-induced diabetic rats. The Open Pharmacol. J. 2008; 2: 63-69.
- Bilia, A.R.; Bergonzi, M.C.; Gallori, S.; Mazzi, G.; Vincieri. F.F.; Stability of the constituents of calendula, milk-thistle and passion flower tinctures by LC-DAD and LC-MS. J. Pharm. Biomed. Anal. 2002; 30: 613-624.
- Veiga AAS: Isolamento e quantificação de flavonoides e abordagem das atividades antioxidante e antimicrobiana de Jatropha gossypiifolia L. 2008. 67 f. Dissertation (MSc) - Federal University of Pará, Instituto de Ciências da Saúde, Belém, 2008. Programa de Pós-graduação em Ciências Farmacêuticas. Access www.capes.gov.br/servicos/banco-de-teses, 16/07/2013.
- Bilia, AR; Salvini, D; Mazzi, G; Vincieri, FF; Characterization of Calendula Flower, Milk-Thistle Fruit, and Passion Flower Tinctures by HPLC-DAD and HPLC-MS Chromatographia 2001; 53: 210-215.
- Ola SS, Giaccherini C, Innocenti M, Vincieri FF, Akindahunsi AA, Mulinacci N: HPLC/DAD/MS characterisation and analysis of flavonoids and cynnamoil derivatives in four Nigerian green-leafy vegetables. Food Chemistry 2009; 115: 1568–1574.
- Xie C, Veitch NC, Houghton PJ, Simmonds MSJ: Flavone C-Glycosides from Viola yedoensis MAKINO. Chem. Pharm. Bull. 2003; 51(10): 1204-1207.
- Grayer RJ, Kite GC, Abou-Zaid M, Archer LJ: The application of atmospheric pressure chemical ionisation liquid chromatography–mass spectrometry in the chemotaxonomic study of flavonoids: characterisation of flavonoids from Ocimum gratissimum var. gratissimum Phytochem. Anal. 2000; 11: 257–267
How to cite this article:
Barbosa WLR, Vincieri FF, Gallori S, Pinto LN, Silva ASB and Anunciacao JN: Characterisation of Flavonoid glycosides in Pharmacopoeial preparation of Cissus verticillata (L) Nicolson & C. E. Jarvis) using HPLC-DAD and HPLC-MS. Int J Pharm Sci Res 2013: 4(10); 3871-3876. doi: 10.13040/IJPSR. 0975-8232.4(10).3871-76
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
18
3871-3876
378KB
1398
English
IJPSR
W. L. R. Barbosa*, F. F. Vincieri , S. Gallori, L. N. Pinto , A. S. B. Silva and J. N. Anunciacao
LaCrEM, Faculty of Pharmacy, Federal University of Pará, Rua Augusto Corrêa, nº 01, CEP 66075-110, Guamá, Belém, Pará, Brazil
barbosa@ufpa.br
14 April, 2013
23 June, 2013
20 September, 2013
http://dx.doi.org/10.13040/IJPSR.0975-8232.4(10).3871-76
01 October, 2013